Literature DB >> 16303308

Time-dependent inhibitors of trypanothione reductase: analogues of the spermidine alkaloid lunarine and related natural products.

Chris J Hamilton1, Ahilan Saravanamuthu, Christiane Poupat, Alan H Fairlamb, Ian M Eggleston.   

Abstract

The macrocyclic spermidine alkaloid lunarine 1 from Lunaria biennis is a competitive, time-dependent inhibitor of the protozoan oxidoreductase trypanothione reductase (TryR), a promising target in drug design against tropical parasitic diseases. Various molecules related to 1 and the alkaloid itself have been synthesized in racemic form and evaluated against TryR in order to determine the key features of 1 that are associated with time-dependent inhibition. Kinetic data are consistent with an inactivation mechanism involving a conjugate addition of an active site cysteine residue onto the C-24-C-25 double bond of the tricyclic nucleus of 1. Comparison of data for synthetic (+/-)-1, the natural product, and other derivatives 7-10 from L. biennis confirms the importance of the unique structure of the tricyclic core as a motif for inhibitor design and reveals that the non-natural enantiomer may be a more suitable scaffold upon which thiophilic groups may be presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16303308     DOI: 10.1016/j.bmc.2005.11.004

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  Trypanothione reductase: a viable chemotherapeutic target for antitrypanosomal and antileishmanial drug design.

Authors:  M Omar F Khan
Journal:  Drug Target Insights       Date:  2007-06-19

2.  Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening.

Authors:  Lorenzo Turcano; Esther Torrente; Antonino Missineo; Matteo Andreini; Marina Gramiccia; Trentina Di Muccio; Ilaria Genovese; Annarita Fiorillo; Steven Harper; Alberto Bresciani; Gianni Colotti; Andrea Ilari
Journal:  PLoS Negl Trop Dis       Date:  2018-11-26

3.  Leishmania mexicana Trypanothione Reductase Inhibitors: Computational and Biological Studies.

Authors:  Félix Matadamas-Martínez; Alicia Hernández-Campos; Alfredo Téllez-Valencia; Alejandra Vázquez-Raygoza; Sandra Comparán-Alarcón; Lilián Yépez-Mulia; Rafael Castillo
Journal:  Molecules       Date:  2019-09-04       Impact factor: 4.411

4.  Investigation of trypanothione reductase as a drug target in Trypanosoma brucei.

Authors:  Daniel Spinks; Emma J Shanks; Laura A T Cleghorn; Stuart McElroy; Deuan Jones; Daniel James; Alan H Fairlamb; Julie A Frearson; Paul G Wyatt; Ian H Gilbert
Journal:  ChemMedChem       Date:  2009-12       Impact factor: 3.466

5.  Synthesis and evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) analogues as inhibitors of trypanothione reductase.

Authors:  Stephen Patterson; Deuan C Jones; Emma J Shanks; Julie A Frearson; Ian H Gilbert; Paul G Wyatt; Alan H Fairlamb
Journal:  ChemMedChem       Date:  2009-08       Impact factor: 3.466

6.  Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis.

Authors:  John L Richardson; Isabelle R E Nett; Deuan C Jones; Mohamed H Abdille; Ian H Gilbert; Alan H Fairlamb
Journal:  ChemMedChem       Date:  2009-08       Impact factor: 3.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.